HC upholds validity of Bihar pharmacist rules

Patna:  The Patna high court on Thursday upheld the constitutional validity of the Bihar Pharmacists Cadre (Amendment) Rules, 2014, which prescribe a diploma in pharmacy (D.Pharma) as the minimum educational qualification for the direct recruitment of pharmacists in the state.

A division bench comprising Acting Chief Justice Ashutosh Kumar and Justice Partha Sarthy delivered the judgement while disposing of a batch of writ petitions filed by Sanjeev Kumar Mishra and 120 other petitioners.

The bench, while appreciating the submissions of advocate general P K Shahi, held that the state govt is legally competent to frame rules prescribing a minimum educational qualification suited to its healthcare infrastructure.
The court noted that a diploma in pharmacy includes 500 hours of intensive hospital training and practical duties. It observed that determining the necessity of such training for the appointment of pharmacists falls within the executive wisdom of the state govt and the high court would not interfere with such policy decisions.

The court further held that the requirement of a diploma as an essential qualification is neither arbitrary nor discriminatory towards candidates holding higher degrees such as a bachelor or master in pharmacy. It clarified that the state’s pharmacists cadre rules provide an avenue for such candidates to be considered, provided they also hold a D. Pharma qualification.

The court also ruled that the Bihar Pharmacists Cadre Rules, 2014, do not contravene the directives of the Pharmacy Council of India (PCI), the central regulatory authority for the pharmacy profession.
Senior advocates Yadu Vansh Giri, Satyadarshi Sanjay, Mrigank Mauli, Abhinav Srivastav, Md Mumtaz Uddin and Prashant Sinha argued the case on behalf of the petitioners. Advocate general P K Shahi represented the state. Senior advocate Jitendra Singh appeared on behalf of the Pharmacy Council of India while senior advocate Lalit Kishore represented aspirants who had intervened to oppose the writ petitions.

Related Posts

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…

Lilly takes 6 companies to court for selling retatrutide knockoffs

Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Lilly takes 6 companies to court for selling retatrutide knockoffs

Lilly takes 6 companies to court for selling retatrutide knockoffs

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch